Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Nutr Cancer ; 72(8): 1378-1389, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31763931

RESUMEN

Although, oral cancer therapies have been developed for decades, patient survival rates have not changed. Side effects of chemotherapy and radiotherapy reduce quality of life of patients and it remains difficult to treat oral cancers due to the presence of cancer stem cells (CSCs) that cause recurrence and metastasis. Therefore, we search for natural products that affect oral cancer cells including oral cancer stem cells. In the present study, we investigated the anticancer effects of Raphanus sativus L. seed (RSLS) extracts on oral squamous cell carcinoma KB cells and CSC-like KBCD133+ cells. CD133 plays an important role in CSCs and physically binds to ß-catenin to activate the ß-catenin signaling targets. Therefore, a natural extract that can inhibit ß-catenin act in may be effective anticancer drug acquiring CSC. Of the natural product extract candidates, RSLS extracts induced apoptosis in KB and KBCD133+ cells and inhibited nuclear translocation of ß-catenin cell migration and invasion rates. Treatment of RSLS extracts resulted in increases of Axin and it leds to reductions of ß-catenin in KB and KBCD133+ cells. Hence, the result suggests that RSLS are potential candidate for anticancer drug against oral cancer cells and CSCs.AbbreviationsCSCcancer stem cellsOSCCsquamous cell carcinoma cellsRSLSRaphanus sativus L. seed.


Asunto(s)
Neoplasias de Cabeza y Cuello/tratamiento farmacológico , Células Madre Neoplásicas/efectos de los fármacos , Extractos Vegetales/farmacología , Raphanus/química , Carcinoma de Células Escamosas de Cabeza y Cuello/tratamiento farmacológico , beta Catenina/antagonistas & inhibidores , Apoptosis/efectos de los fármacos , Línea Celular Tumoral , Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Regulación hacia Abajo , Neoplasias de Cabeza y Cuello/metabolismo , Neoplasias de Cabeza y Cuello/patología , Humanos , Células KB , Células Madre Neoplásicas/metabolismo , Células Madre Neoplásicas/patología , Semillas/química , Carcinoma de Células Escamosas de Cabeza y Cuello/metabolismo , Carcinoma de Células Escamosas de Cabeza y Cuello/patología
2.
Biochem Biophys Res Commun ; 504(1): 352-358, 2018 09 26.
Artículo en Inglés | MEDLINE | ID: mdl-30190131

RESUMEN

Wnt/ß-catenin pathway plays an important role in adipogenesis and osteogenesis. To search for novel activators of the Wnt/ß-catenin pathway, we screened plant extracts and found that Sangusorba officinalis L. extracts (SOE) could increase ß-catenin expression level and nuclear accumulation in 3T3-L1 and MC3T3-E1 cells. It was confirmed that SOE could effectively control adipo-osteogenic differentiation. SOE inhibited adipocyte differentiation of 3T3-L1 cells, markedly decreased intracellular lipid accumulation, and decreased expression levels of key adipogenic transcription factors including PPARγ, C/EBPα, and SREBP-1c. SOE enhanced ALP activity and terminal osteoblast differentiation which was confirmed by Alizarin Red S staining of MC3T3-E1 cells. In ex vivo culture, SOE significantly increased the thickness of calvarial bone in mice. Taken together, our results indicate that SOE could be used as a potential therapeutic agent for dual-treatment of anti-obesity and anti-osteoporosis via activation of Wnt/ß-catenin pathway.


Asunto(s)
Adipocitos/citología , Osteogénesis , Sanguisorba/química , Vía de Señalización Wnt/efectos de los fármacos , Células 3T3 , Células 3T3-L1 , Adipocitos/efectos de los fármacos , Animales , Huesos , Técnicas de Cultivo de Célula , Diferenciación Celular , Células HEK293 , Humanos , Ratones , Osteoporosis , Extractos Vegetales/metabolismo , Proteínas Wnt/metabolismo , beta Catenina/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA